HEPATITIS D, CHRONIC
Clinical trials for HEPATITIS D, CHRONIC explained in plain language.
Never miss a new study
Get alerted when new HEPATITIS D, CHRONIC trials appear
Sign up with your email to follow new studies for HEPATITIS D, CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Doctors seek clues to stop lifelong hepatitis d drugs
Disease control OngoingThis study aims to find signs in the blood that show which hepatitis D patients can safely stop their bulevirtide medication. It involves 20 patients who have been successfully treated for at least a year. Doctors will stop their treatment and monitor them for 48 weeks to see who…
Matched conditions: HEPATITIS D, CHRONIC
Phase: NA • Sponsor: Hannover Medical School • Aim: Disease control
Last updated Apr 04, 2026 07:36 UTC
-
New drug combo targets Hard-to-Treat hepatitis d
Disease control OngoingThis study is testing two investigational drugs, VIR-2218 and VIR-3434, in people with chronic hepatitis D virus infection. The goal is to see if these drugs can safely reduce the amount of virus in the blood and improve liver health. About 95 participants will receive the drugs,…
Matched conditions: HEPATITIS D, CHRONIC
Phase: PHASE2 • Sponsor: Vir Biotechnology, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC